Spain · Delayed Price · Currency is EUR Cirsa Enterprises Statistics
Total Valuation
BME:CIRSA has a market cap or net worth of EUR 2.29 billion. The enterprise value is 4.29 billion.
| Market Cap | 2.29B |
| Enterprise Value | 4.29B |
Important Dates
The last earnings date was Thursday, July 30, 2026.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | Apr 29, 2026 |
Share Statistics
BME:CIRSA has 167.96 million shares outstanding. The number of shares has increased by 181.32% in one year.
| Current Share Class | 167.96M |
| Shares Outstanding | 167.96M |
| Shares Change (YoY) | +181.32% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.00% |
| Owned by Institutions (%) | 3.18% |
| Float | 39.45M |
Valuation Ratios
The trailing PE ratio is 23.95 and the forward PE ratio is 8.13. BME:CIRSA's PEG ratio is 0.29.
| PE Ratio | 23.95 |
| Forward PE | 8.13 |
| PS Ratio | 0.94 |
| PB Ratio | 2.64 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.05 |
| P/OCF Ratio | 3.40 |
| PEG Ratio | 0.29 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.57, with an EV/FCF ratio of 7.57.
| EV / Earnings | 37.63 |
| EV / Sales | 1.75 |
| EV / EBITDA | 5.57 |
| EV / EBIT | 10.73 |
| EV / FCF | 7.57 |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 2.54.
| Current Ratio | 0.79 |
| Quick Ratio | 0.71 |
| Debt / Equity | 2.54 |
| Debt / EBITDA | 2.87 |
| Debt / FCF | 3.90 |
| Interest Coverage | 2.13 |
Financial Efficiency
Return on equity (ROE) is 25.86% and return on invested capital (ROIC) is 10.15%.
| Return on Equity (ROE) | 25.86% |
| Return on Assets (ROA) | 6.58% |
| Return on Invested Capital (ROIC) | 10.15% |
| Return on Capital Employed (ROCE) | 12.31% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 155,021 |
| Profits Per Employee | 7,223 |
| Employee Count | 15,766 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 25.95 |
Taxes
In the past 12 months, BME:CIRSA has paid 69.54 million in taxes.
| Income Tax | 69.54M |
| Effective Tax Rate | 30.15% |
Stock Price Statistics
The stock price has decreased by -5.79% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -5.79% |
| 50-Day Moving Average | 12.87 |
| 200-Day Moving Average | 13.60 |
| Relative Strength Index (RSI) | 59.75 |
| Average Volume (20 Days) | 131,379 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:CIRSA had revenue of EUR 2.44 billion and earned 113.88 million in profits. Earnings per share was 0.57.
| Revenue | 2.44B |
| Gross Profit | 1.97B |
| Operating Income | 401.69M |
| Pretax Income | 230.62M |
| Net Income | 113.88M |
| EBITDA | 769.41M |
| EBIT | 399.27M |
| Earnings Per Share (EPS) | 0.57 |
Balance Sheet
The company has 325.66 million in cash and 2.21 billion in debt, with a net cash position of -1.88 billion or -11.21 per share.
| Cash & Cash Equivalents | 325.66M |
| Total Debt | 2.21B |
| Net Cash | -1.88B |
| Net Cash Per Share | -11.21 |
| Equity (Book Value) | 869.31M |
| Book Value Per Share | 3.83 |
| Working Capital | -146.87M |
Cash Flow
In the last 12 months, operating cash flow was 674.83 million and capital expenditures -108.85 million, giving a free cash flow of 565.98 million.
| Operating Cash Flow | 674.83M |
| Capital Expenditures | -108.85M |
| Depreciation & Amortization | 279.89M |
| Net Borrowing | -366.02M |
| Free Cash Flow | 565.98M |
| FCF Per Share | 3.37 |
Margins
Gross margin is 80.79%, with operating and profit margins of 16.44% and 4.66%.
| Gross Margin | 80.79% |
| Operating Margin | 16.44% |
| Pretax Margin | 9.44% |
| Profit Margin | 4.66% |
| EBITDA Margin | 26.62% |
| EBIT Margin | 13.81% |
| FCF Margin | 23.16% |
Dividends & Yields
This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 3.29%.
| Dividend Per Share | 0.45 |
| Dividend Yield | 3.29% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 92.02% |
| Buyback Yield | -181.32% |
| Shareholder Yield | -178.04% |
| Earnings Yield | 4.96% |
| FCF Yield | 24.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BME:CIRSA is 19.73, which is 41.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 19.73 |
| Price Target Difference | 41.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 7.90% |
| EPS Growth Forecast (3Y) | 15.54% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:CIRSA has an Altman Z-Score of 1.39 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.39 |
| Piotroski F-Score | 8 |